Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs SnagRx

AM Rx
Graded #490

Lower grade

vs+8
SnagRx
Graded #387

Higher grade

The verdict

SnagRx takes it — 57.9/100 to 49.9/100.

SnagRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. SnagRx is a cash-pay GLP-1 telehealth service from Modern Metabolic Medicine, Inc.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAM Rx +15
51
36
Dose & formulationAM Rx +1
65
64
Clinical oversightSnagRx +35
41
76
Labs & monitoringSnagRx +4
49
53
FulfillmentSnagRx +13
58
71
Contract termsSnagRx +35
20
55
AM Rx · left barSnagRx · right bar

The numbers

MetricAM RxSnagRx
WeighScore49.9/10057.9/100
GradeCC
Scorecard rank#490#387
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)$299/mo (starting dose, compounded)
TirzepatideNot disclosed$399/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
AM Rx

Graded #490 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
SnagRx

Graded #387 · C

Strengths

  • Compounded semaglutide ($99/mo) and tirzepatide ($149/mo) on launch discount, flat-priced at every dose
  • Names four partner pharmacies in Terms (RedRock, Health Warehouse, Precision Compounding, Triad Rx)
  • Available in all 50 states plus Washington D.C. per Terms
  • Telemed visit, prescription and free 1-2 day shipping included; no insurance or membership
  • Cancel anytime; full refund if disqualified by the medical provider

Where it loses points

  • Headline $99/$149 prices are discounted from $299/$399 standard; a countdown timer pressures signup
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only
  • Refunds only available before medication is ordered; all sales otherwise final
  • Binding JAMS arbitration under Delaware law; class-action waiver

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard